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Abstract
Vitamins are essential micronutrients for normal development. Great 
emphasis has been placed on vitamin D for bone development and maintenance. 
However, other vitamins also influence bone health. While some of them are 
more beneficial to bone and increase bone mass by increasing bone formation, 
calcium deposition and stimulate osteoblastogenesis, higher concentrations of 
others have deleterious effects causing fragile bones and increasing the risk 
of fractures. Knowledge about the effects of these vitamins will help in better 
maintenance of bone. This review focuses on the information available on 
vitamins A,B,C,E and K on bone health. Existing information supports vitamin 
C and K to play a role in bone formation and calcification. Vitamin E in low 
amounts and some of the B vitamins may also be beneficial to bone. There is 
very limited data supporting the favorable effects of vitamin A. 
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for normal metabolism or they can activate and deactivate important 
signaling pathways. Therefore, adequate vitamin intake is necessary 
for normal development of all the different organ systems, in an 
individual, including the skeletal system.
Bone is an active organ undergoing modeling and remodeling 
throughout life. During childhood and adolescence, bone modeling 
takes place helping the bones to grow. Throughout this period, bone 
formation is dominant and needs balanced nutrients to increase 
bone mass. After attaining peak bone mass, the skeletal system is 
maintained by bone remodeling and bone resorption increases, 
steadily decreasing bone mass with age. Several vitamins play a 
role in building bones and maintaining them through the years. An 
imbalance or decrease intake of these vitamins can negatively impact 
the bone remodeling process by increasing bone resorption. When 
bones do not get the nourishment required for normal growth and 
development, they are weak and are easily susceptible to fractures 
putting individuals at risk of developing osteoporosis. Osteoporosis is 
a medical condition that is seen in one out of two women and one out 
of four men [1]. People diagnosed with osteoporosis have low bone 
mass and fragile bones that breaks with minor trauma. In women, 
bone loss is accelerated during menopause and post menopause. 
However, close to half the trabecular bone is lost in women and men 
before the age of 50 [2].
Bone formation and resorption are sequestered events involving 
many different proteins. Bone formation is accomplished by 
osteoblasts. Osteoblasts differentiate from bone marrow stem 
cells (mesenchymal stem cells) under the influence of growth 
factors(insulin-like growth factor I (IGF-I)), cytokines (Interleukin 
(IL) -18 (IL-18)), several transcriptional regulators (homeodomain 
proteins, surfactant proteins, Runt homology domain transcriptional 
factors), hormones (estrogen, parathyroid hormone (PTH), vitamin 
D), prostaglandin E1 (PGE1), on costatin M, adrenomedullin and 
leptin [3]. Mature osteoblasts first form the collagen matrix and then 
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Introduction
An individual’s well-being is dependent on several factors such 
as: diet, physical activity, availability of resources etc. Among diet, the 
balance in intake of macronutrients such as carbohydrates, proteins, 
lipids and micronutrients like vitamins and minerals is important. 
Vitamins form some of the most essential micronutrients. They are 
implicated in many diseases that can be reversed by supplementing 
or limiting the intake of vitamins.
Vitamins are divided into water soluble (B vitamins, C) or fat 
soluble (vitamins A, D, E, K) depending on their solubility. Their 
categorization also refers to the mode by which they are absorbed in 
the body after digestion. Water soluble vitamins are absorbed with 
the help of sodium dependent transporters, while fat soluble vitamins 
follow the fat absorption pathway and are packed in chylomicrons for 
delivery to the organs. The availability and storage of these vitamins is 
dependent on ones intake. They serve as important catalyst for many 
enzymatic activities; are converted to essential compounds required 
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with the help of osteocalcin start the mineralization process [3]. On 
the other hand, cells involved in bone resorption, are multinucleated 
cells called osteoclasts and differentiate from hematopoietic cells. 
Their differentiation takes place under the influence of several 
cytokines (IL-1, IL-6, IL-7, and tumor necrosis factor-α (TNFα), 
hormones (PTH, estrogen and vitamin D) and prostaglandin E2 
(PGE2). These cells, dissolve the matrix proteins [4] and release the 
minerals from the bone leading to cavities and increasing the fragility 
of the bone [3]. 
This review focuses on the influence of vitamins on bone health. 
Articles were collected from Pubmed and Medline databases. The 
keywords used were: vitamin A and bone, retinoic acid (RA) and bone, 
vitamin B and bone, thiamine and bone, riboflavin and bone, vitamin 
B3 and bone, vitamin B5 and bone, vitamin B6 and bone, vitamin B7 
and bone, vitamin B9 and bone, vitamin B12 and bone, vitamin C and 
bone, vitamin E and bone, and vitamin K and bone. As the role of 
vitamin D on bone health is very well established, this review focuses 
on the influence of other vitamins on bone strength, bone mineral 
density (BMD), micro architecture and pathways of bone. 
Water Soluble Vitamins
There are two water soluble vitamins – vitamin B complex and 
vitamin C. Both vitamin B complex and C are not stored in the body 
and have to be supplemented in the diet regularly. They are absorbed 
with the help of sodium dependent transporters [5].
Vitamin B complex
B Vitamins are composed of 8 compounds: vitamin B1 (thiamine), 
vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B5 (pantothenic 
acids), vitamin B6 (pyridoxine, pyridoxal, pyridoxamine), vitamin 
B7 (biotin), vitamin B9 (folic acid), vitamin B12 (cobalamine) [5]. Off 
these, thiamine prevented malformations of the palate related to 
teratogony [6]. Studies on the direct effects of thiamine on bone are 
lacking. Sources of the different B vitamin are listed in Table 1 [7-9].
In vitro studies using Vitamin B2 (riboflavin) in MC3T3 cells, 
which can be differentiated to become osteoblasts, have shown to 
enhance the differentiation process [10]. Osteoclastogenesis was also 
decreased by riboflavin through the expression of osteoprotegrin 
which is secreted by the osteoblastic stromal cells [10]. In patients 
with elevated homocysteine, due to MTHFR C677T polymorphism, 
riboflavin was not associated with fracture risk [11] especially in the 
femoral neck [12].
In vitro studies using vitamin B3 (niacin and niacin amide) have 
shown no effect on the bone mineral content (BMC) in male leghorn 
chicken, and it also decreased bone strength [13,14]. This may be 
because niacin can stimulate oxidative stress in bone marrow cells 
[15] – a factor that stimulates bone resorption. However, in diabetic 
mice, niacin supplementation improved blood flow after ischemia 
[16] which may be beneficial to bone health.
Limited studies have reported the effects of vitamin B5 
(pantothenic acid) on bone. Deficiency of this vitamin changed the 
osteogenesis in the tibia of rats, in a time dependent manner. Reports 
concluded that, longer deficiency caused more damage to the tibia 
[17,18]. Additionally, longer periods of pantothenic acid deficiency, 
led to decreased osteoblast proliferation, osteogenesis and increased 
trabecular bone resorption which led to loss of trabeculae [17]. 
The effects of vitamin B6 (pyridoxine, pyridoxal and 
pyridoxamine), on bone health, has been reported in a few in 
vivo studies. Studies on male Wister rats showed that vitamin B6 
deficiency decreased cross-link intermediates and impaired crosslink 
formation [19]. Similar effects were also reported in chick embryo. 
When treated with vitamin B6 antagonist there was decreased cross-
linking of collagen supporting vitamin B6 supplementation during 
pregnancy [20]. In addition, vitamin B6 deficiency decreased alkaline 
phosphatase (ALP), bone healing and tibial strength [21].
Vitamin B7 (biotin) deficiency affects bone formation. In broiler 
chicken, vitamin B7 deficiency decreased periosteal bone apposition, 
bone formation rate, osteoid perimeter and IGF-I [22,23]. Biotin may 
require riboflavin to maintain tibial BMD, strength and stiffness as 
demonstrated in young turkey chicks [24].
Vitamin B9 (folic acid and folate) is well known for their effects on 
Vitamin Source
Vitamin B1 (Thiamine)
Found in cereals (rice, wheat, maida, rava, poha, etc.) breads, fortified cereals and pasta, pulses or lentils (dals such as moong dal, masoor 
dal, chana dal etc), legumes (whole pulses such as whole moong, channa, chowli, rajmah), dark green leafy vegetables such as spinach, 
fenugreek, lettuce, cabbage, asparagus etc. soy foods, whole grains like wheat germ, fish, egg, milk, meat, pork ham etc, nuts such as 
almonds and pecans. Daily value: 1mg for men; 0.8mg for women.
Vitamin B2 (Riboflavin) 
Some of the best sources of riboflavin are chicken, fish, eggs, legumes (like peas and lentils), milk and milk products such as yogurt and 
cheese, nuts,  green leafy vegetables like spinach, broccoli, asparagus, and fortified cereals also supply significant amounts of riboflavin to 
the diet. Daily value: 1.3mg for men; 1.1mg for women.
Vitamin B3 (Niacin) It is found in chicken, salmon and in fishes like canned tuna – they are an excellent source of niacin. Vegetarians can get their source of 
niacin from legumes, pasta and whole wheat. Daily value: 17mg for men; 13mg for women.
Vitamin B6 (Pyridoxine)




Yogurt and avocado are both excellent sources of pantothenic acid, but it is also available in a wide variety of foods such as legumes 
including lentils and split peas, sweet potatoes, mushrooms and broccoli. Daily Value: 4-7 mg for adults.
Vitamin B7 (Biotin)
Liver and egg yolks are the richest dietary sources of biotin, but fortunately this B vitamin is well distributed throughout the food supply, so it 
is doubtful that anyone eating a balanced, varied diet will experience a deficiency. Salmon, pork and avocado are good sources; most fruits 
and vegetables contain a little biotin, as do cheeses and grain foods. Daily value: 30-100 mg for adolescents and adults.
Vitamin B9 (Folate, folic 
acid, or folacin)
To remember which foods are high in folate, remember that the word folate has the same root as the word foliage. Leafy greens such as 
spinach, fenugreek, turnip greens, asparagus, etc and other fresh fruits and vegetables are all excellent sources of folate. Liver, dried 




Animal foods are the only natural source of vitamin B12. It is found naturally in fish, red meat, poultry, milk, milk products, cheese, and 
eggs. But, many products, including soy products and cereals, are fortified with B12 so it is widely available in the food supply. Other good 
natural sources include shellfish, such as clams, mussels and crab, fin fish and beef. Daily value: 0.0015mg for adults.
Table 1: Sources of the various vitamin B compounds [7-9].
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the nervous system. In the rat embryo skull bone, folic acid decreased 
TGFβ1 and TGF-1 expression [25]. Otherwise, there is no evidence 
that folic acid directly affects bone. However, when adequate amount 
of folate is not consumed, there is decreased BMD and trabecular 
thickness in the vertebra of postmenopausal women which can be 
reversed with folate supplementation [26,27]. Additional studies, 
showed that folic acid could reduce the accumulation of aluminum in 
organs such as bone, kidney and brain, thereby, reducing the toxicity 
[28].
Vitamin B12 (cobalamine) can act on both osteoblasts and 
osteoclasts [29-31]. Its deficiency decreased bone mass by stimulating 
osteoclastogenesis mainly by increasing methyl malonic acid and 
homocysteine [29]. It also influenced ALP secretion in patients’ 
deficient with vitamin B12 and decreased BMD [30-34]. In vegetarians 
decreased intake of vitamin B12 increased bone turnover [35] which 
may lead to net loss of bone. 
Decreased consumption of vitamin B12 and folic acid decreased 
BMD in older men which led to greater bone loss [26,36,37]. One 
of the functions of vitamin B12 and B6 is to regulate homocysteine. 
Hyperhomocysteinemia is caused by deficiency of folate and B12 [38]. 
For every mmol/l of homocysteine there is 4% increase in fracture 
risk [32,39]. Universally, homocysteine is associated inversely with 
BMD, as it reduced BMD in older women [33,40-44]. Increased 
homocysteine and low vitamin B12 were significantly associated with 
high levels of bone turnover markers and increased fracture risk 
[45]. High concentrations of homocysteine may also interfere with 
the cross linking of collagen, thereby, decreasing the stability and 
strength of collagen network [46]. Additional evidence showed that 
homocysteine may increase osteoclast formation and activity [46-
48], bone turnover [44] and bone marker levels [44]. Due to plasma 
homocysteine levels association with osteoporosis [49], it has been 
suggested that levels of circulating homocysteine can be used as 
a marker of fragility in females>75 years of age [44]. In male rats, 
however, there was no change in the BMD in the tibia, although 
there was decreased blood flow to the bone and reduced biochemical 
properties [50]. Homocysteine is reported to bind with collagen 
resulting in decreased bone strength [32,51]. Supplementation 
with folic acid, vitamins B12 and vitamin B6 effectively reduced 
homocysteine levels [46]. 
Except for vitamin B3, other vitamin B compounds are beneficial 
to bone health. It was interesting to note that there were scanty 
reports on vitamin B1 and bone. Vitamin B12 and B6 plays a major role 
in lowering homocysteine levels, thereby reducing osteoclast activity 
and decreasing bone turnover.
Vitamins C (ascorbic acid)
Vitamin C is absorbed in the small intestine into the brush border 
cells using the sodium dependent vitamin C transporter (SVCT) 
proteins. When this transporter is overexpressed, it is able to increase 
mineralization and calcium deposition. It is also reported to help 
with the bone marrow stromal cells to differentiate into osteoblasts 
as knockdown of this transporter inhibitedosteogenesisin these cells 
[52]. In bone marrow aspirates from athymic BALB/C ru mice with 
subcutaneous implant, ALP and calcium deposition on scaffolds 
increased [53] with vitamin C supplementation. A list of the sources, 
serving sizes and recommended daily value of vitamin C is given in 
Table 2 [7,9].
In male Sprague Dawley (SD) rats, there was increased 
bioavailability of calcium as corbate compared to calcium acetate [54]. 
In female guinea pigs, lower intake of vitamin C was associated with 
decreased collagen synthesis resulting in lower levels of collagen, ALP 
and osteocalcin [55,56]. Decreased intake of vitamin C also increased 
bone turnover and reduced transition of salts to the crystalline form 
[57], whereas, long term deficiency of vitamin C, decreased skeletal 
maturation and showed bone abnormalities in female guinea pigs 
[58]. Total deprivation of vitamin C in guinea pigs led to destruction 
of the proximal tibia with micro fractures. Additionally, damage to 
the diaphysis led to Genu Varums (bow legs) [59]. Treatment with 
vitamin C restored the tibia and formation of trabecular bone at the 
growth cartilage by sub periosteal thickening [59] and development 
of trabecular callus. However in dogs, vitamin C supplementation 
did not modify BMC [60] and the tibial breaking strength or 
egg shell thickness in hens also was not altered due to vitamin C 
supplementation [61]. Inversely, in chicks, it is reported that ascorbic 
acid may be involved in mobilizing calcium and phosphorus soon 
after injection but had no effect on bone resorption or the bone 
formation process [62].
Vitamin C deficiency accelerated bone loss and increased 
fractures, in the femur of senescence marker protein 30 knockout 
mice [63]. It is known to help in the differentiation of osteoblasts and 
deficiency promotes osteoblasts to transition into adipocytes [63]. 
It may accomplish this by upregulating the expression of proximal 
proliferator-activated receptor gamma (PPARγ) [63] which is an 
important cofactor required for the hydroxylation of collagen and 
is necessary for osteoblast proliferation [64]. ALP expression is also 
dependent on as corbate levels. It influenced collagen organization 
to form the protein matrix for the deposition of minerals [64]. 
In addition, it is established that vitamin C deficiency inhibits 
calcification process [64].
Source Serving Size Vitamin Content (mg)
Guava, raw ½ cup 188
Red sweet pepper, raw ½ cup 142
Red Sweet pepper, cooked ½ cup 116
Kiwi fruit 1 medium 70
Orange, raw 1 medium 70
Orange juice, ¾ cup ¾ cup 61-93
Green pepper, sweet, raw ½ cup 60
Green pepper, sweet, cooked ½ cup 51
Grapefruit juice ¾ cup 50-70
Vegetable juice cocktail ¾ cup 50
Strawberries, raw ½ cup 49
Brussel sprouts, cooked ½ cup 48
Cantaloupe ¼ medium 47
Papaya, raw ¼ medium 47
Kohlrabi, cooked ½ cup 45
Daily value: 90 mg for men; 75 mg for women
Table 2: List of sources, serving size, and vitamin C content in foods [7-9].
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In postmenopausal women, BMD decreased in response to lower 
vitamin C intake in a dose dependent manner, however, there was 
no such effect in males [65]. Another study reported a 3% increase 
in BMD at the ultra-distalmidshaft, radii, hip and lumbar spine in 
postmenopausal women [66]. It also increased ALP and enhanced 
collagen synthesis as well as stimulated procollagen [66]. Short 
term (7 weeks) vitamin C supplementation in children (boys) did 
not show any changes in biochemical markers like pyridoxiline and 
deoxypyridoxiline [67].
Fluoride toxicity in monkeys and copper toxicity in rabbits were 
attenuated by supplementation with vitamin C [68,69]. Vitamin C 
and Zinc positively influenced bone geometry, size and strength in 
children [70].
Overall, vitamin C is required for osteoblast differentiation and 
is important for bone formation. It is also an anti-oxidant, therefore, 
may act by reducing oxidative stress and positively influencing bone.
Fat Soluble Vitamins
All fat soluble vitamins are absorbed along with fatty acid and 
delivered to the liver as fatty acid. It is dependent on bile salts and can 
be transported in chylomicrons. These vitamins are stored in the body 
just like fatty acids.
Vitamin A (retinoids)
Vitamin A consists of a group of compounds – retinal, retinyl 
ester, retinol and RA [5]. Vitamin A can affect the translational 
processes in cells and nuclear receptors like retinoic acid receptor 
(RAR) and retinoid X receptor (RXR) help in this process. The 
sources, serving sizes and recommended intake of vitamin A and pro 
vitamin A are listed in Table 3 [7,9].
RA treatment of growth plate chondrocytes, induced annexins II, 
V and VI to form Ca2+ channels and influx calcium into the cells. It 
also stimulated the release of ALP to initiate mineralization [71]. In 
addition, RA stimulated chondrocyte differentiation by upregulating 
the expression of bone morphogenetic protein (BMP) [72]. In human 
and murine cells, RA inhibited Receptor Activator of Nuclear Factor 
kappa-B Ligand (RANΚL) stimulated osteoclast differentiation [73] 
and in the fish, Atlantic cod, RA decreased bone resorption [74]. 
On the other hand, there are also reports that RA decreased BMP2 
expression thereby stimulating osteoclastogenesis [75] and induced 
bone loss. Interestingly, it has been used as a method to induce bone 
loss in female rats [76]. There are also reports showing reduction of 
mineralization with RA supplementation [77] and RA has a negative 
effect on the oral bone mass in rats [78]. 
One of the receptors, retinoic acid receptor γ (RARγ) is a potent 
inhibitor of osteoclastogenesis as it decreased nuclear factor activated 
T cells (NFAT) activation, granulocyte colony stimulating factor 
(G-CSF) and RANKL, and also increased bone formation [79]. 
Carotenoids from fruits and vegetables act through the anti-oxidant 
pathway to reduce bone resorption [80].
Vitamin A supplementation in female rats, increased BMD 
but decreased trabecular area with no change in cortical thickness 
or stiffness and levels of osteocalcin [81]. In IEC-6 cells, vitamin A 
supplementation up regulated ALP [82]. Vitamin A can also promote 
bone formation through the BMP2/7 heterodimer [83]. It is also 
reported that vitamin A supplementation in postmenopausal women, 
had no age related increase in risk for fractures or any changes in 
BMD [84] and the mechanical properties of the bone [85]. However, 
the beneficial effect of vitamin A is more in the trabecular bone than 
the cortical bone in aged rats [85]. When vitamin A is consumed with 
polyunsaturated fatty acids (PUFAs) they act on different pathways 
and while vitamin A can cause malformations, PUFAs increased bone 
formation independent of each other [86]. 
However, some reports concluded that supplementation with 
vitamin A did not show any beneficial or detrimental effects in 
humans and animal models. In women, decreased intake of vitamin A 
did not have a detrimental effect on bone [84] and in men, short term 
supplementation with vitamin A did not influence bone turnover 
[87]. Similarly, studies on dogs supplemented with vitamin A also did 
not show any detrimental effects on bone [88]. 
Another vitamin A compound, retinol has a negative effect on 
bone as it decreased BMD in mice and rats [89-94]. Increased intake 
of retinol increased bone fragility and fracture risk at different sites 
including the femur neck, Ward’s triangle, trochanter region of 
the proximal femur, lumbar spine [93,95].  In cases where there is 
decreased vitamin D, increased intake of retinol further increased 
fracture risk [96]. However, retinol with retinol binding protein 4 
showed decreased osteoclast activity in humans (males) [97]. Early 
studies have shown that decreased vitamin A increased osteoblast 
activity [98].
In addition, there are studies that have reported several negative 
effects on bone, especially when vitamin A was given to children. 
Problems reported include building of fontanelle, increase in 
intracranial pressure, anoxia, drowsiness, instability followed by 
brain damage [99,100]. Dhem et al. have reported several other 
detrimental effects of vitamin A supplementation including lesions in 
the endocortical surface of the tibia, cavities and demineralization on 
the periosteal surface and cancellous bone, enlargement of Haversian 
canals  [77,91,101] and hypervitaminosis A which is associated with 
long bone fractures [77,91]. High intake of cod liver oil also increased 
the risk of fractures [102].
Sources Serving Size Vitamin Content (IU)
Liver, beef, cooked* 3 oz. 27,185
Liver, chicken, cooked* 3 oz. 12,325
Carrot juice, canned* ½ cup 22,567
Carrots, boiled* ½ cup slices 13,418
Spinach, frozen, boiled* ½ cup 11,458
Kale, frozen, boiled ½ cup 9558
Carrots, raw 7 ½ in 8666
Vegetable soup, canned, chunky, ready-
to-serve 1 cup 5820
Cantaloupe 1 cup cubes 5411
Spinach, raw 1 cup 2813
Apricots with skin, juice pack ½ cup 2063
Daily value: 5000IU for adults and children age 4 and older
Table 3: List of sources, serving size, and vitamin A content in foods [7-9].
*high in retinol activity equivalents.
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Although vitamin A has shown some bone protective effects by 
up-regulating BMP, and RAR inhibited osteoclastogenesis, there are 
many reports indicating that consuming high levels of this vitamin 
may be deleterious to both long and parietal bones.
Vitamin E (tocopherols)
Vitamin E consists of the tocopherols and tocotrienols. Each of 
them include4 vitamers but α tocopherol (αTF) is the biologically 
active form and has been studied very extensively. Table 4 lists the 
sources, caloric content with the recommended daily value intake of 
vitamin E [7,9]. 
Vitamin E levels have been directly related to the bone status 
in humans as osteoporotic subjects have less circulating vitamin 
E levels [103,104]. Many in vivo studies have reported the benefits 
of αTF. Supplementation with αTF increased mineralizing surface, 
bone formation rates and strength of bones in OVX rats [105,106]. 
In addition, it also decreased osteoclast surface at medium dose 
as well as in low doses and reduced oxidative stress [107-109]. In 
postmenopausal rat model, trabecular bone volume, trabecular 
number increased and trabecular separation decreased with 
αTF supplementation [106,107]. Biochemical markers like ALP, 
osteocalcin and IGF-I expression increased with αTF [108,110] and 
decreased TRAP. In male rats αTF prevented bone loss due to disuse 
of hind limb by decreasing cyclooxygenase – 2 (COX-2) [111]. Older 
mice showed increased yield stress, ultimate load and stiffness of 
bone [110], however this effect was not seen in younger mice with 
αTF supplementation. However, the effect of vitamin E is site specific 
as it positively correlates with BMD in the spine and not in the long 
bones [112]. Young (6 months old) and old (24 months old) C57Bl/6 
mice when fed vitamin E showed increased bone strength and matrix 
protein with no change in BMD. This effect was more in older mice 
than younger mice. There was also decreased PGE2 and increased 
IGF-I formation [110]. In female rats, vitamin E also increased 
calcium content [113] and also increased calcium availability and 
decreased certain free radical production; however, αTF did not 
improve calcium in the bone [114]. The beneficial effects of vitamin E 
are attributed to the tocotrienols in the vitamin E mixture used in the 
study. The ratio of vitamin E to lipids is significantly associated with 
decreased BMD of the lumbar spine of in postmenopausal women 
[115,116]. Moreover, αTF may modulate γTF by reducing its levels 
and affect bone formation [115].
In lower concentrations, αTF can protect bone and at high 
concentrations is detrimental to bone as they can interfere with the 
function of vitamin K and other isoforms of vitamin E [117-119]. 
Moreover, the source of vitamin E may also make a difference [109].
Vitamin K
Vitamin K includes two compounds – vitamin K1 (Phylloquinone) 
and K2 (Menaquinone). The major function of vitamin K is to 
promote coagulation of blood but recently there is evidence that it 
is also involved in maintaining bone health [120,121] by increasing 
bone formation and reducing bone resorption [122]. Table 5 has the 
list of sources and serving size with the daily value for vitamin K [7,9]. 
Vitamin K is implicated in carboxylating a couple of proteins 
that are involved in the bone formation process - matrix Gla proteins 
and osteocalcin [123-125]. Matrix Gla protein has high affinity to 
calcium and functions as a modulator of calcium availability [126]. 
Osteocalcin is a protein secreted by osteoblasts and is an important 
bone biochemical marker associated with increase in bone formation 
[127-129]. Age related decrease in γ carboxylation of osteocalcin 
takes place [130].
Several studies have shown that osteocalcin is under carboxylated 
and does not mobilize the calcium for mineralization, thereby, 
decreasing bone formation and vitamin K supplementation 
attenuated this effect by carboxylating osteocalcin [131,132], 
therefore, is beneficial to bone [133].
Many in vivo studies on animal models have shown the 
benefits of vitamin K supplementation. Male rats, supplemented 
with menaquinone, showed decreased under carboxylated 
osteocalcinalong with increased mineral crystallinity and hardness 
in the tibiae [134]. OVX rats, fed vitamin K, showed higher bone 
strength and decreased risk of fractures in the tibia and femur by 
increasing trabecular bone volume [135,136] trabecular number and 
decreasing trabecular separation, osteoclast number/bone surface and 
osteoclast surface/bone surface [137]. Vitamin K also promoted bone 
Source Serving Size Vitamin Content (mg)
Sunflower seeds, dry roasted 1 oz. 7.4
Sunflower oil, high linoleic 1 Tbsp. 5.6
Cottonseed oil 1 Tbsp. 4.8
Safflower oil, high oleic 1 Tbsp. 4.6
Hazelnuts (filberts) 1 oz. 4.3
Mixed nuts, dry roasted 1 oz. 3.1
Turnip greens, frozen, cooked ½ cup 2.9
Tomato paste ¼ cup 2.8
Pine nuts 1 oz. 2.6
Peanut butter 2 Tbsp. 2.5
Tomato Puree ½ cup 2.5
Tomato sauce ½ cup 2.5
Canola oil 1 Tbsp. 2.4
Wheat germ, toasted, plain 2 Tbsp. 2.3
Daily value: 30IU for adults and children above age 4.
Table 4: List of sources, serving sizes, and Vitamin E content in foods [7-9].
Source Serving Size Vitamin Content (cg)
Brussel sprouts ½ cup 460
Turnips greens, raw, chopped 1 cup 364
Broccoli ½ cup 248
Lentils, dry ½ cup 214
Cauliflower ½ cup 150
Kale, cooked ½ cup 150
Spinach, raw, chopped ½ cup 149
Garbanzo beans, dry ½ cup 132
Swiss chard ½ cup 124
Daily value: 75µg for men and women
Table 5: List of sources, serving sizes, and Vitamin K content in foods [7-9].
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healing in a rodent model of osteotomy [138]. In gastroectomized 
SD rats, vitamin K2 supplementation attenuated the decrease in 
ultimate force and increased stiffness of the femoral diaphysis [139]. 
Male orchidectomized rats, showed increased bone MAR, BFR, BV/
TV and BV [140-142] and improved trabecular micro architecture 
with vitamin K supplementation [132]. Similar benefits of vitamin K 
supplementation on the trabecular structure and bone volume in tail 
suspended rats [143] was also reported.
Children with better vitamin K status had increased bone mass 
[144]. In early menopausal women, under caroboxylated osteocalcin 
was negatively associated with BMD in the total hip, femoral neck, 
and lumbar spine [145,146]. Elderly institutionalized men and 
women are recommended to consume higher amounts of vitamin 
K than the recommended adequate intake to maintain skeletal 
health [147]. In healthy postmenopausal women, supplementation 
of vitamin K2, significantly, decreased loss in vertebral height and 
increased bone strength, BMC and BMD in the lumbar spine, femoral 
neck and hip bone geometry [148-151]. Biochemical markers of bone 
metabolism like serum under carboxylated osteocalcin decreased and 
γ carboxylated osteocalcin increased, with vitamin K supplementation 
[152,153]. Healthy women in the ages of 30-88 years showed decreased 
under carboxylated osteocalcin especially in older women, among the 
cohort studied [154]. However, another study reported decreased 
bone turnover in both the young and elderly, when supplemented 
with vitamin K [155]. A direct relationship between BMD and lower 
concentrations of phylloquinone in postmenopausal women was also 
reported [156]. Plasma phylloquinone levels were inversely associated 
with N- terminal telopeptide and under carboxylated osteocalcin 
in girls (3-16 years of age) [157]. Interestingly, decreased vitamin K 
intake decreased BMD in female but not in males [158]. Vitamin K 
also induced IL-1α, PGE2 [159] in patients with femur neck fractures 
or lower BMD had decreased levels of circulating vitamin K [160,161]. 
Vitamin K supplementation also protected bone by modulating bone 
turnover during space flight [162] and osteoporotic patients with 
vitamin K2 supplementation showed increased lumbar BMD [163].
Vitamin K when supplemented with alendronate increased total 
and trabecular BMD at the distal metaphysis of the femur, in mice. It 
also increased the strength of the bone [164]. Combined treatment 
with risendronate and vitamin K prevented glucocorticoid induced 
bone loss and decreased bone formation and bone erosion in rats 
[165-167]. In addition, when OVX rats were given vitamin K in 
combination with bisphosphonates, pretreatment with vitamin K 
improved the strength, BMD, BMC and trabecular structure in the 
femur [168,169]. OVX rats with, vitamin K2 and Raloxifene showed 
greater strength in the femoral neck [170]. Vitamin K supplementation 
may also reduce drug induced osteoporosis [155].
Although there are many studies showing the benefits of vitamin 
K on bone, there are some studies that did not show any benefits. 
Early menopausal women did not show any benefits with vitamin 
K supplementation for 1 year [171]. Six months of vitamin K 
supplementation did not show any significant increase in BMD in 
pre and perimenopausal women [172]. In OVX rats, vitamin K did 
not change the BMD in the distal femur [173]. This may be due to the 
short term treatment or the concentration of vitamin K given to the 
subjects or there might have been drug/nutrient interactions.
There is ample evidence to show that vitamin K is essential for the 
carboxylation of osteocalcin and improves calcium deposition in the 
matrix. Therefore, adequate vitamin K is necessary to maintain the 
mineral content and strength in bones.
Combination of Vitamins on Bone
Combination of vitamins C and E partially prevented bone 
destruction due to heparin [174]. αTF interacts with vitamin K and 
other vitamin E isomers to increase pro-oxidative effects. Vitamin D 
and K may have synergistic effects [175-177]. Decreased vitamin E 
and C increased fracture risk in smokers [95,103]. No influence of 
vitamin E supplementation on BMD of the lumbar and femoral neck 
(FN) has also been reported in postmenopausal women [178].
Conclusions
In summary, among the water soluble vitamins, research supports 
that vitamin C was most beneficial to bone. This may be because it is 
a potent anti-oxidant and can help in osteoblast differentiation. Of 
the different B vitamins, riboflavin, B6, biotin, folic acid and B12 had 
a positive influence on bone metabolism. This may be by different 
mechanism such as: inhibition of osteoclastogenesis by decreasing 
in IGF-I levels, and interfering with the cross linking of proteins. 
Combination of B vitamins like folic acid, B12 and B6 is probably more 
effective in inhibiting the action of hyperhomocysteinemia. However, 
vitamins B3 had a negative effect on bone because of their pro oxidative 
effects. Of the fat soluble vitamins, vitamin K and E influenced bone 
formation positively, while vitamin A has been reported to have 
more deleterious effects on bone especially when given in high 
concentrations during infancy and childhood. So far, based on the 
available literature, after vitamin D, vitamin K supplementation 
is the most promising. Vitamin K in combination with several 
bisphosphonates increased BMD and strength of long bones. Further 
studies should be conducted to see if vitamin K can maintain bone 
mass with decreased concentrations of bisphosphonates. This will 
reduce the side effects of bisphosphonates considerably. Moreover, 
as pretreatment with vitamin K before bisphosphonates improves 
the strength, BMC and BMD, it may also benefit individuals after 
withdrawal of bisphosphonate treatment. Vitamin K may also help 
diabetic patients, where the matrix is compromised. However, 
more detailed studies on the effects of various vitamins have to be 
Figure 1: Text Here.
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conducted to elucidate the actual benefits of the different vitamins 
in maintaining bone health. The concise effects of vitamins are 
summarized in Figure 1.
An important fact to note is that most of the studies reporting 
the effects of vitamins in humans are self reporting surveys. A 
better understanding of the benefits of vitamins may be obtained by 
interventional controlled studies. It is also important to remember 
that each vitamin has a recommended intake, which should be taken 
into consideration to decrease any undesirable side effects and may 
help maintaining healthy bones. But most importantly, interactions 
of drugs and other nutrients with vitamins should be carefully studied 
before any vitamin supplementation is taken. 
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